|
7MFG
Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer
Deposited 2021-04-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
344–519(176 aa)
Chain D
344–519(176 aa)
Chain I
344–519(176 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.87 Å
|
|
7SCN
Structure of H1 NC99 influenza hemagglutinin bound to Fab 310-63E6
Deposited 2021-09-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
18–339(322 aa)
Chain B
343–520(178 aa)
Chain C
18–339(322 aa)
Chain D
343–520(178 aa)
Chain G
18–339(322 aa)
Chain I
343–520(178 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;TBS buffer, PH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE;Blotting time: 5.5 s
Blotting force: 0
Waiting time: 7 s
|
Resolution 3.02 Å
|
|
7SCO
Structure of H1 influenza hemagglutinin bound to Fab 310-39G10
Deposited 2021-09-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
18–339(322 aa)
Chain B
343–520(178 aa)
Chain C
18–339(322 aa)
Chain D
343–520(178 aa)
Chain G
18–339(322 aa)
Chain I
343–520(178 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;TBS buffer, PH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE;Blotting time: 5.5 s
Blotting force: 0
Waiting time: 7 s
|
Resolution 3.37 Å
|
|
8D21
Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer
Deposited 2022-05-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
344–519(176 aa)
Chain C
344–519(176 aa)
Chain G
344–519(176 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;PBS
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.96 Å
|
|
8UR5
I53_dn5 nanoparticle displaying the trimeric HA heads with heptad domain, TH-1heptad-I53_dn5 (local refinement of TH-1heptad)
Deposited 2023-10-25
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
64–280(217 aa)
Chain B
64–280(217 aa)
Chain C
64–280(217 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.70 Å
|